US 9839688
Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
granted A61KA61K2039/505A61K31/352
Quick answer
US patent 9839688 (Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer) held by Provectus Pharmatech, Inc. expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K31/352, A61K31/365, A61K38/193